Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Parallel-Group Study on the Duration Response of Highly Concentrated On Label Dose (COLD) of Xeomin® Compared to the On Label Dose and Concentration (OLD) in Subjects With Moderate to Severe Dynamic Glabellar Lines

NCT05305768 is registered in ClinicalTrials.gov with Clinical Testing of Beverly Hills as lead sponsor.

NCT NCT05305768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05305768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Parallel-Group Study on the Duration Response of Highly Concentrated On Label Dose (COLD) of Xeomin® Compared to the On Label Dose and Concentration (OLD) in Subjects With Moderate to Severe Dynamic Glabellar Lines
Lead sponsor
Clinical Testing of Beverly Hills
Phase
Phase 1
Overall status
Unknown status
Start date
May 1, 2022
Completion date
February 28, 2023
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar frown lines